本届大赛赛题设计仍为"技术赛"与"案例赛"相结合的形式，围绕"安全治理"和"创新发展"两大方向设置赛题，吸引了全 国顶尖团队和技术精英参与。酶赛生物报送的案例《人工智能赋能新型酶催化非天然手性氨基化合物合成》从一众高水平 项目中脱颖而出，取得佳绩。 第六届中国人工智能大赛由国家互联网信息办公室、公安部指导，厦门市人民政府主办，旨在进一步推动人工智能技术创 新发展，促进人工智能与实体经济深度融合，加快构建以大模型为代表的人工智能技术应用落地。 【SynBioCon】 获 悉， 12 月 12 日，第六届中国人工智能大赛颁奖典礼在厦门圆满收官。酶赛生物携 AI 驱动的合成 生物制造创新方案 ，从全国强队中突围，斩获人工智能赋能合成生物制造创新案例赛 A 级荣誉，同时获奖的还有中科院 天工所孙周通团队等，再次验证我们在人工智能与产业融合赛道的硬核实力。 Bio-based 2026 第十一届生物基大会暨展览 The 11th Bio-based Industry Conference & Exhibition 跨越新周期 澎湃新生机 7 场行业评选 新叶奖(第四届) 11 场论坛+7 大同期活动 关键词 | 底层技 ...

Core Viewpoint - The article highlights the rapid growth and innovation in the synthetic biology industry in Wuqing, Tianjin, particularly through the success of Tianjin Xiaowei Biotechnology Co., Ltd., which focuses on the development and production of probiotics, showcasing a shift towards domestic production and technological advancement in the sector [2][3][5]. Company Summary - Tianjin Xiaowei Biotechnology Co., Ltd. has grown into a leading enterprise in the probiotic industry, with over 10,000 strains collected and preserved, and 52 mature production strains [3]. - The company has developed 21 invention patents and collaborates with multiple research institutions, contributing to the development and production transformation of over 20 strains [3]. - The expected annual output value for the company is projected to exceed 50 million yuan, with plans for further capacity expansion in Wuqing [3]. Industry Summary - Wuqing has established a synthetic biology industry ecosystem that includes gene sequencing, gene synthesis, strain screening, and industrial fermentation, supported by leading projects such as the Tianjin University Synthetic Biology Frontier Research Institute [5][6]. - The research institute has successfully created a synthetic pathway for rose alcohol in yeast, marking a significant advancement in green and sustainable biomanufacturing [5]. - The region is home to 300 biopharmaceutical companies, with 56 of them being above-scale enterprises, and has achieved an industrial output value of 4.336 billion yuan from January to October 2025 [8]. - The Wuqing district aims to develop a trillion-level biopharmaceutical industry cluster, integrating biopharmaceuticals, medical devices, precision medicine, and synthetic biology manufacturing [8].

随着十五五年规划建议的正式发布，推动生物制造"成为新的经济增长点"被确定为国家级前瞻布局，这标志着生物制造已从一项前沿技术正式上升至战略 高度。 上市公司作为各行业产业基石，其战略布局、技术优势与资本动向，无疑成为观察中国生物制造从蓝图迈向现实的最生动样本。在这一历史性机遇下，对 合成生物领域上市公司的梳理或许正是一次关键的产业"透视"。 动脉网根据同花顺数据梳理发现，截至2025年你2月9日，A股市场里共有161家公司均属于"合成生物"概念，总市值约1.69万亿，平均市值达到105亿。 从养猪行业的牧原股份，到做维生素的新和成，再到做创新药的华东医药，不同行业的企业都在用合成生物技术改造自身的业务。甚至包括化妆品、宠物 食品甚至电池材料相关企业，都开始与合成生物相结合。 这161家企业就像一面镜子，照出了中国合成生物产业的真实面貌——既有已经盈利的传统业务升级，也有还在摸索的新技术尝试；既有医药健康这样的 主力赛道，也有农业、化工这些正在被改造的传统领域。 01 市值金字塔：161家公司，1.6万亿市场的真实格局 | 市值区间（亿元） | 公司数量 | 出 | 代表企业（市值从高到低） | | --- | ...

Core Viewpoint - Rhein Biotech, a leader in the plant extraction industry, is undergoing a significant change in control and asset acquisition, led by Defu Capital, which manages over $34 billion in funds, aiming to inject strong growth momentum into the company [1][2]. Group 1: Company Overview - Rhein Biotech has over 300 standardized plant extraction technologies and has established multiple national-level research platforms, including a "National Tropical Fruit Processing Technology R&D Center" and a "Postdoctoral Research Station" [1]. - The company holds a stable global market share of 20%-25% in monk fruit extract and ranks among the top three globally in stevia extract sales [1]. Group 2: Capital Cooperation - Defu Capital, a seasoned investment institution in the healthcare and consumer sectors, is acquiring control through its Guangzhou Defu Nutrition Investment platform, with 99.926% of the investment coming from its core operating entity, reflecting strong confidence in Rhein Biotech's future [2]. - The acquisition includes Beijing Jinkangpu Food Technology Co., a leading company in the food premix sector, which has three modern production bases and a capacity of over 10,000 tons [2]. Group 3: Strategic Synergy - The collaboration between Rhein Biotech and Jinkangpu is expected to create a robust industrial ecosystem, where Rhein's natural raw materials will supply Jinkangpu's production system, ensuring quality raw materials for end products [2]. - Jinkangpu's strong customer base and international channels will open new markets for Rhein's high-value products, enhancing product value significantly [2]. Group 4: Future Prospects - The partnership is anticipated to accelerate the transformation of technology for Rhein Biotech, integrating its R&D capabilities with Jinkangpu's application strengths in food and health products [3]. - As consumer demand for "natural health" continues to rise, this strategic alliance is expected to further solidify Rhein Biotech's leading position in the global natural health products market [3].

人民财讯12月9日电，据湖北日报，12月9日，湖北省委书记、省人大常委会主任王忠林主持研究推 进"51020"先进制造业产业集群高质量发展工作。王忠林强调，要在科技创新引领上持续加力。瞄准"四 个面向"，深入实施关键技术攻关"尖刀"工程，加快高水平科技自立自强。瞄准产业发展方向，大力开 拓人形机器人、脑机接口、6G、合成生物等新领域新赛道。瞄准产业化需求，推动科技创新和产业创 新深度融合，打通从科技强到产业强、经济强的通道。 ...

Core Insights - The seminar focused on the integration of synthetic biology and modern animal husbandry in Pingliang, aiming to establish a model for high-quality livestock industry in the western region of China [1] Group 1: Event Overview - The seminar was held on December 8, organized by various agricultural and scientific institutions from Tianjin and Pingliang, with over 50 participants including experts and local practitioners [1] - The event aimed to deepen technological cooperation between Tianjin and Gansu, emphasizing the collaborative model of "technology research in Tianjin, application in Pingliang" [1] Group 2: Key Presentations - Chen Jiexin, Vice President of Pingliang Agricultural Science Institute, highlighted synthetic biology as a core engine for agricultural modernization and industry upgrading, viewing the seminar as a valuable opportunity for collaboration [2] - Dr. Ma Yi, Chief Expert of Tianjin Dairy (Meat Sheep) Industry Technology System Innovation Team, discussed the importance of technological innovation in the livestock industry and proposed specific suggestions for integrating key technologies [2] - Zhang Xiaoli, Deputy General Manager of Baikui Rui (Tianjin) Biotechnology, presented on the applications of synthetic biology in agriculture, emphasizing its role in producing functional proteins and probiotics, and reducing antibiotic use [2] Group 3: Industry Perspectives - Zhang Tianti, Chairman of Auchan Yuan Intelligent Equipment Co., Ltd., discussed the potential of synthetic biology to cultivate nutrient-enhanced super crops and promote high-end health products through biomanufacturing [3] - The seminar included interactive discussions where local technicians engaged with experts on technology adaptability and the transformation of scientific achievements [3] - The event was seen as a model for technological empowerment in agriculture, promoting collaboration between eastern and western regions of China [3]

Core Viewpoint - The article discusses the challenges faced by large enterprises, particularly in the Chinese dairy industry, as they transition from rapid expansion to a focus on existing market competition. It highlights how Mengniu Dairy has strategically navigated these challenges through acquisitions and operational improvements to strengthen its market position and prepare for future growth [1][2]. Group 1: Five-Year Layout Overview - Mengniu has strategically acquired upstream dairy sources and core product lines while expanding globally, demonstrating resilience despite market fluctuations and operational challenges [2][5]. - The acquisition of Modern Dairy and China Shengmu has enhanced Mengniu's integrated supply chain, with Modern Dairy operating 47 farms and producing over 3 million tons of milk annually [2]. - Despite facing a downturn in raw milk prices, Mengniu has focused on cost reduction and operational efficiency, resulting in a 23.3% increase in cash flow for Modern Dairy in the first half of 2025 [2]. Group 2: Market Performance and Innovations - Mengniu's acquisition of Bellamy's in 2019 faced challenges, leading to a significant impairment charge, but the brand has shown recovery with over 20% revenue growth in the first half of 2025 [5]. - Mengniu has successfully integrated its cheese business through the acquisition of Miaokelando, achieving a market share of over 38% in the cheese sector by mid-2025 [6]. - The company has also made strides in the Southeast Asian market with its ice cream brand Aisle, achieving over 20 billion yuan in revenue and a 34% market share in Indonesia [6]. Group 3: Financial Stability and Shareholder Returns - Mengniu's financial performance has shown improvement, with a 13.4% increase in operating profit and a 46.2% rise in cash flow in the first half of 2025 [8][9]. - The company has demonstrated strong cash flow management, providing over 2 billion yuan in cash dividends and achieving a shareholder return rate exceeding 4% during a challenging market period [9]. Group 4: Future Growth Strategy - Looking ahead, Mengniu aims to deepen its "One Body, Two Wings" strategy, focusing on consolidating its core business while expanding through innovation and global outreach [12]. - The company plans to enhance its nutritional health platform and expand its overseas presence, particularly in Southeast Asia and beyond, to drive new growth opportunities [17][21]. - Mengniu's commitment to innovation is evident in its investments in health-focused products and partnerships, positioning itself to meet evolving consumer demands [18][20].

以往，酵母细胞计数或通过人工使用显微镜完成，或通过非自动化的传统设备完成，存在费时费力又不 够精准的问题。"市场上精酿啤酒质量、口感参差不齐，就在于一些企业细胞计数的不精准，甚至干脆 省去这一环节。"潘登直言。 □ 本报记者许雯斐 通讯员耿瑞雪王若宇 12月3日晚9点，南京酵富生物技术有限公司(以下简称"酵富生物")创始人潘登风尘仆仆地从外地赶回南 京，便径直返回公司进行盘点。这次当天往返的紧急出差，源于客户对新产品的迫切需求。 酵富生物位于江北新区智能制造产业园，就在近日，其推出颠覆啤酒酿造行业的新产品，全量全自动酵 母细胞计数仪JFYCC-S1，该仪器仅需五分钟即可完成从取样到生成报告的全流程。 潘登此次出差，正是去帮客户调试刚订购的新设备。"我们在全国有1000多家客户，得知我们推出这一 新产品，很多客户主动联系订购。"潘登说。 酵母是神奇的酿酒"魔法师"，通过精准调控温度与菌群配比，可以生成不同风味物质，例如酯类产生果 香，酚类带来花香。当代人追捧各式精酿啤酒的迷人风味，正是酵母在其中扮演关键角色。 一罐啤酒发酵时，工作中的酵母细胞数量可达百亿级。而酵母细胞数会影响啤酒风味和发酵的稳定，因 此，唯有精 ...

Core Insights - Taizhou is undergoing a transformation in its manufacturing landscape, shifting from traditional metalworking to advanced technologies such as satellite manufacturing and AI-driven computing [1][3][6] Manufacturing Transition - The city is moving from traditional manufacturing, characterized by automotive and machinery production, to new sectors like aerospace and digital technologies [3][4] - Taizhou's satellite manufacturing, exemplified by the production of "Blue Carbon No. 1," has adopted an automotive-style mass production model, reducing costs by approximately 45% and increasing annual production capacity to 500 satellites [3][4] Computing and AI Development - The establishment of the Southeast Zhejiang Intelligent Computing Center marks a strategic move to enhance local computing power, crucial for the digital economy [5][6] - The center has partnered with leading domestic AI chip companies, significantly improving the efficiency of data processing and enabling rapid deployment of new technologies [5][6] Industry Innovation - Companies like Crystal Optoelectronics and Four Brothers Rope have demonstrated significant advancements in their respective fields, achieving breakthroughs in optical technology and deep-sea cable manufacturing [7][9][10] - Crystal Optoelectronics successfully transitioned to semiconductor optical processes, while Four Brothers Rope developed high-strength cables for deep-sea applications, showcasing the potential for traditional industries to innovate [9][10] Collaborative Innovation - The establishment of mixed-ownership innovation centers, combining state-owned enterprises, private companies, and academic institutions, aims to address high-end manufacturing challenges [11][12] - This collaborative approach has led to significant advancements in high-end CNC systems, with a focus on practical solutions rather than theoretical research [11][12] Financial Support for Innovation - Taizhou's local government has implemented a robust financial ecosystem to support innovation, including industry funds and insurance products tailored for startups [14][15] - This financial backing is crucial for sustaining long-term innovation and reducing risks associated with new ventures [14][15] Conclusion - Taizhou's transformation illustrates the potential for traditional manufacturing sectors to evolve through technology and innovation, contributing to regional economic development and setting a model for other areas [15]

Core Insights - China's innovative drugs, new energy vehicles, and AI electronic products have emerged as the new three major export items, with innovative drug licensing output reaching $93.7 billion in the first three quarters of 2025, accounting for nearly 40% of the global total, reflecting the strong momentum of China's high-quality development [1][24]. Group 1: Major Technological Achievements - The launch of the National Bio-Manufacturing Industry Innovation Center, led by the Shenzhen Institute of Advanced Technology, marks China's only national-level innovation platform in the bio-manufacturing sector, focusing on green low-carbon, bio-agriculture, and medical health [3]. - The completion of the second phase of the Seventh Affiliated Hospital of Sun Yat-sen University in Shenzhen, a modern hospital designed with a patient-centered approach, aims to enhance healthcare innovation in the region [5]. - The Shenzhen Science and Technology Innovation Fund officially commenced operations, aiming to support original innovation and technology breakthroughs through early-stage investments [7]. Group 2: Infrastructure and Collaboration - The establishment of user committees for major scientific infrastructures like synthetic biology research facilities and brain analysis facilities will ensure efficient operation and high-level research output [9]. - The unveiling of the Regional Technology Transfer and Transformation Center for Higher Education Institutions in the Guangdong-Hong Kong-Macao Greater Bay Area will accelerate the conversion of academic research into practical applications [11]. - The emphasis on open collaboration has led to the formation of a global innovation network, enhancing regional cooperation and attracting international research institutions to participate in the development of the Guangming Science City [12]. Group 3: Talent and Innovation Ecosystem - Over the past seven years, Guangming Science City has attracted more than 3,100 high-level talents, including 59 academicians, forming a robust talent pool that supports innovation in fields like brain science and artificial intelligence [24]. - The establishment of a comprehensive open-sharing mechanism for major scientific infrastructures has allowed over 200 users, including universities and research institutions, to access advanced research facilities [25]. - The rise of industrial innovation has led to the development of several billion-dollar industry clusters, including high-end medical devices and synthetic biology, fostering a deep integration of technological and industrial innovation [26].